Metabolomics is referred as the large-scale study of small molecules, commonly known as metabolites, within tissues, cells, biofluids or organisms. Innovative development in informatics and analytical technologies and increasing pharmaceutical and biotech R&D expenditure are expected to significantly contribute in the market growth during forecast period. Other factors such as ongoing research on metabolomics biomarker and extensive application of metabolomics biomarker such as in colorectal cancer detection are also expected to drive the market growth. Further, increasing pharmaceutical and biotech R&D expenditure is also contributing in the market. In 2017, the global Metabolomics Biomarker market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. This report focuses on the global Metabolomics Biomarker status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metabolomics Biomarker development in United States, Europe and China. The key players covered in this study Biocrates Life Sciences Biomark Diagnostics Chenomx Creative Proteomics Evotec Human Metabolome Technologies Merck Metabolomic Diagnostics Metabolon Ovid Therapeutics Market segment by Type, the product can be split into Gas chromatography High-performance liquid chromatography Ultra-performance liquid chromatography Nuclear magnetic resonance Mass spectrometry Surface-based mass analysis Bioinformatics Market segment by Application, split into Toxicological studies Drug testing Cancer Cardiovascular disorders Neurological disorders Inborn errors of metabolism Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Metabolomics Biomarker status, future forecast, growth opportunity, key market and key players. To present the Metabolomics Biomarker development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Metabolomics Biomarker are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Metabolomics Biomarker Market Size Growth Rate by Type (2013-2025) 1.4.2 Gas chromatography 1.4.3 High-performance liquid chromatography 1.4.4 Ultra-performance liquid chromatography 1.4.5 Nuclea
